K020752

Substantially Equivalent

VARELISA CARDIOLIPIN IGG ANTIBODIES, MODELS 15548 & 15596

Applicant: Pharmacia Deutschland GmbH
Product code: MID
Advisory panel: Immunology
Date received: 2002-03-07
Decision date: 2002-05-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Freiburg, DE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.